Luke Sergott
Stock Analyst at Barclays
(2.14)
# 2,919
Out of 4,996 analysts
309
Total ratings
41.05%
Success rate
-5.39%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $490 → $550 | $464.24 | +18.47% | 27 | Sep 11, 2025 | |
| A Agilent Technologies | Maintains: Equal-Weight | $125 | $123.39 | +1.30% | 11 | Aug 29, 2025 | |
| NTRA Natera | Maintains: Overweight | $190 → $210 | $162.97 | +28.86% | 4 | Aug 8, 2025 | |
| TXG 10x Genomics | Maintains: Overweight | $13 → $15 | $11.72 | +27.99% | 13 | Aug 8, 2025 | |
| FTRE Fortrea Holdings | Maintains: Underweight | $5 → $6 | $8.68 | -30.88% | 11 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $65 → $55 | $53.57 | +2.67% | 6 | Aug 7, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $155 → $165 | $148.56 | +11.07% | 8 | Aug 7, 2025 | |
| BRKR Bruker | Maintains: Overweight | $46 → $43 | $31.04 | +38.53% | 5 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Overweight | $15 → $13 | $11.84 | +9.80% | 25 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Underweight | $85 → $90 | $91.69 | -1.84% | 19 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $82.70 | +8.83% | 1 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $155 → $180 | $163.79 | +9.90% | 20 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $300 → $450 | $496.79 | -9.42% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $185 | $179.56 | +3.03% | 23 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2 → $1.5 | $1.21 | +23.97% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $15.82 | -17.83% | 21 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $215 → $225 | $184.84 | +21.73% | 40 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $245 | $261.52 | -6.32% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $125.61 | +19.42% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $55 | $43.90 | +25.28% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,325 | $1,204.43 | +10.01% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $11 → $14 | $11.80 | +18.64% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $60 | $60.03 | -0.05% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $291.71 | +19.98% | 18 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $45 | $26.91 | +67.22% | 17 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $110 | $84.06 | +30.86% | 9 | Apr 10, 2025 |
Thermo Fisher Scientific
Sep 11, 2025
Upgrades: Overweight
Price Target: $490 → $550
Current: $464.24
Upside: +18.47%
Agilent Technologies
Aug 29, 2025
Maintains: Equal-Weight
Price Target: $125
Current: $123.39
Upside: +1.30%
Natera
Aug 8, 2025
Maintains: Overweight
Price Target: $190 → $210
Current: $162.97
Upside: +28.86%
10x Genomics
Aug 8, 2025
Maintains: Overweight
Price Target: $13 → $15
Current: $11.72
Upside: +27.99%
Fortrea Holdings
Aug 7, 2025
Maintains: Underweight
Price Target: $5 → $6
Current: $8.68
Upside: -30.88%
Exact Sciences
Aug 7, 2025
Maintains: Overweight
Price Target: $65 → $55
Current: $53.57
Upside: +2.67%
Charles River Laboratories International
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $155 → $165
Current: $148.56
Upside: +11.07%
Bruker
Aug 4, 2025
Maintains: Overweight
Price Target: $46 → $43
Current: $31.04
Upside: +38.53%
Avantor
Aug 4, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $11.84
Upside: +9.80%
Illumina
Aug 1, 2025
Maintains: Underweight
Price Target: $85 → $90
Current: $91.69
Upside: -1.84%
Aug 1, 2025
Initiates: Overweight
Price Target: $90
Current: $82.70
Upside: +8.83%
Jul 25, 2025
Maintains: Equal-Weight
Price Target: $155 → $180
Current: $163.79
Upside: +9.90%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $300 → $450
Current: $496.79
Upside: -9.42%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $165 → $185
Current: $179.56
Upside: +3.03%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $2 → $1.5
Current: $1.21
Upside: +23.97%
Jun 24, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $15.82
Upside: -17.83%
Jun 24, 2025
Maintains: Overweight
Price Target: $215 → $225
Current: $184.84
Upside: +21.73%
Jun 24, 2025
Initiates: Equal-Weight
Price Target: $245
Current: $261.52
Upside: -6.32%
Jun 24, 2025
Initiates: Overweight
Price Target: $150
Current: $125.61
Upside: +19.42%
Jun 24, 2025
Initiates: Overweight
Price Target: $55
Current: $43.90
Upside: +25.28%
Jun 24, 2025
Initiates: Overweight
Price Target: $1,325
Current: $1,204.43
Upside: +10.01%
May 8, 2025
Upgrades: Overweight
Price Target: $11 → $14
Current: $11.80
Upside: +18.64%
May 1, 2025
Maintains: Overweight
Price Target: $55 → $60
Current: $60.03
Upside: -0.05%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $291.71
Upside: +19.98%
Apr 10, 2025
Maintains: Overweight
Price Target: $58 → $45
Current: $26.91
Upside: +67.22%
Apr 10, 2025
Maintains: Overweight
Price Target: $140 → $110
Current: $84.06
Upside: +30.86%